Ghrelin, obesity and diabetes

Nature Clinical Practice Endocrinology and Metabolism

Volumn 3, Issue 10, 2007, Pages 705-712

  Wiedmer, Petra ^a   Nogueiras, Rubén ^b   Broglio, Fabio ^c   D'Alessio, David ^b   Tschöp, Matthias H ^a,b  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Diabetes; Ghrelin; Metabolic syndrome; Obesity; Obestatin

Indexed keywords

GHRELIN; GHRELIN ANTAGONIST; GLUCOSE; HORMONE ANTAGONIST; HORMONE RECEPTOR; UNCLASSIFIED DRUG;

BODY WEIGHT; DIABETES MELLITUS; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GLUCOSE INTAKE; GLUCOSE METABOLISM; HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; NONHUMAN; NUTRITIONAL STATUS; OBESITY; PARACRINE SIGNALING; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; THERMOGENESIS; VACCINATION;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; ENERGY METABOLISM; HUMANS; OBESITY; PEPTIDE HORMONES;

EID: 34648821994     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0625     Document Type: Review

References (94)

1. Heijboer AC et al. (2006) Gut-brain axis: regulation of glucose metabolism. J Neuroendocrinol 18: 883-894
2. van der Lely AJ et al. (2004) Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25: 426-457
3. Diano S et al. (2006) Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 9: 381-388
4. Despres JP and Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444: 881-887
5. Nogueiras R et al. (2006) Growth hormone secretagogue (ghrelin-) receptors - a complex drug target for the regulation of body weight. CNS Neurol Disord Drug Targets 5: 335-343
6. Kojima M et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660
7. Hosoda H et al. (2003) Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J Biol Chem 278: 64-70
8. Nishi Y et al. (2005) Ingested medium-chain fatty acids are directly utilized for the acyl modification of ghrelin. Endocrinology 146: 2255-2264
9. Camina JP (2006) Cell biology of the ghrelin receptor. J Neuroendocrinol 18: 65-76
10. Gauna C et al. (2006) Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor. Mol Cell Endocrinol 251: 103-111
11. Granata R et al. (2007) Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic β-cells and human islets: involvement of 3′,5′-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-kinase/Akt signaling. Endocrinology 148: 512-529
12. Sun Y et al. (2004) Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 101: 4679-4684
13. Holst B et al. (2003) High constitutive signaling of the ghrelin receptor - identification of a potent inverse agonist. Mol Endocrinol 17: 2201-2210
14. Zhang JV et al. (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310: 996-999
15. Sibilia V et al. (2006) Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. J Endocrinol Invest 29: RC31-RC34
16. Bresciani E et al. (2006) Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. J Endocrinol Invest 29: RC16-RC18
17. Holst B et al. (2007) GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 148: 13-20
18. Seoane LM et al. (2006) Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J Endocrinol Invest 29: RC13-RC15
19. Nogueiras R et al. (2007) Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 148: 21-26
20. Gourcerol G and Tache Y (2007) Obestatin - a ghrelin-associated peptide that does not hold its promise to suppress food intake and motility. Neurogastroenterol Motil 19: 161-165
21. Dun SL et al. (2006) Distribution and biological activity of obestatin in the rat. J Endocrinol 191: 481-489
22. Samson WK et al. (2007) Obestatin acts in brain to inhibit thirst. Am J Physiol Regul Integr Comp Physiol 292: R637-R643
23. Szentirmai E and Krueger JM (2006) Obestatin alters sleep in rats. Neurosci Lett 404: 222-226
24. Lauwers E et al. (2006) Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun 351: 21-25
25. Tolle V et al. (2002) Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology 143: 1353-1361
26. Cummings DE et al. (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50: 1714-1719
27. Tschop M et al. (2000) Ghrelin induces adiposity in rodents. Nature 407: 908-913
28. Tschop M et al. (2001) Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 24: RC19-RC21
29. Overduin J et al. (2005) Role of the duodenum and macronutrient type in ghrelin regulation. Endocrinology 146: 845-850
30. Ariyasu H et al. (2002) Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin. Endocrinology 143: 3341-3350
31. Gottero C et al. (2004) Ghrelin: a link between eating disorders, obesity and reproduction. Nutr Neurosci 7: 255-270
32. Perreault M et al. (2004) Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss. Int J Obes Relat Metab Disord 28: 879-885
33. Yildiz BO et al. (2004) Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci USA 101: 10434-10439
34. English PJ et al. (2002) Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 87: 2984
35. Purnell JQ et al. (2007) Changes in 24-h area-under-the-curve ghrelin values following diet-induced weight loss are associated with loss of fat-free mass, but not with changes in fat mass, insulin levels or insulin sensitivity. Int J Obes (Lond) 31: 385-389
36. Sun Y et al. (2003) Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23: 7973-7981
37. Lawrence CB et al. (2002) Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology 143: 155-162
38. Chen HY et al. (2004) Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145: 2607-2612
39. Tschop M et al. (2002) GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein. Endocrinology 143: 558-568
40. Shuto Y et al. (2002) Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 109: 1429-1436
41. Egecioglu E et al. (2006) Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice. Am J Physiol Endocrinol Metab 290: E317-E325
42. Banks WA et al. (2002) Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 302: 822-827
43. Cowley MA et al. (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37: 649-661
44. Kineman RD et al. (2007) Identification of a mouse ghrelin gene transcript that contains intron 2 and is regulated in the pituitary and hypothalamus in response to metabolic stress. J Mol Endocrinol 38: 511-521
45. Horvath TL (2006) Synaptic plasticity in energy balance regulation. Obesity (Silver Spring) 14 (suppl 5): 228S-233S
46. Olszewski PK et al. (2003) Hypothalamic paraventricular injections of ghrelin: effect on feeding and c-Fos immunoreactivity. Peptides 24: 919-923
47. Currie PJ et al. (2005) Ghrelin is an orexigenic and metabolic signaling peptide in the arcuate and paraventricular nuclei. Am J Physiol Regul Integr Comp Physiol 289: R353-R358
48. Olszewski PK et al. (2003) Neural basis of orexigenic effects of ghrelin acting within lateral hypothalamus. Peptides 24: 597-602
49. Faulconbridge LF et al. (2003) Hyperphagic effects of brainstem ghrelin administration. Diabetes 52: 2260-2265
50. Naleid AM et al. (2005) Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides 26: 2274-2279
51. Guan XM et al. (1997) Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 48: 23-29
52. Zigman JM et al. (2006) Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 494: 528-548
53. Abizaid A et al. (2006) Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 116: 3229-3239
54. Date Y et al. (2002) The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123: 1120-1128
55. Asakawa A et al. (2001) Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120: 337-345
56. Arnold M et al. (2006) Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J Neurosci 26: 11052-11060
57. Wortley KE et al. (2004) Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 101: 8227-8232
58. Erickson JC et al. (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381: 415-421
59. Qian S et al. (2002) Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol 22: 5027-5035
60. Theander-Carrillo C et al. (2006) Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 116: 1983-1993
61. Dornonville de la Cour C et al. (2005) Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice. Gut 54: 907-913
62. Zorrilla EP et al. (2006) Vaccination against weight gain. Proc Natl Acad Sci USA 103: 13226-13231
63. St-Pierre DH et al. (2004) Relationship between ghrelin and energy expenditure in healthy young women. J Clin Endocrinol Metab 89: 5993-5997
64. Yasuda T et al. (2003) Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats. Neurosci Lett 349: 75-78
65. Tang-Christensen M et al. (2003) Ghrelin induces long lasting changes in food intake and locomotor behaviour. Abstract P3-94 presented at the 85th Annual Meeting of the Endocrine Society: 2003, June 19-22, Philadelphia, PA
66. Tang-Christensen M et al. (2004) Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology 145: 4645-4652
67. Barazzoni R et al. (2005) Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am J Physiol Endocrinol Metab 288: E228-E235
68. McCowen KC et al. (2002) Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents. J Endocrinol 175: R7-R11
69. Saad MF et al. (2002) Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 87: 3997-4000
70. Purnell JQ et al. (2003) Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab 88: 5747-5752
71. Broglio F et al. (2001) Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86: 5083-5086
72. Broglio F et al. (2004) Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 89: 3062-3065
73. Sun Y et al. (2006) Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 3: 379-386
74. Zigman JM et al. (2005) Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest 115: 3564-3572
75. Date Y et al. (2002) Ghrelin is present in pancreatic α-cells of humans and rats and stimulates insulin secretion. Diabetes 51: 124-129
76. Volante M et al. (2002) Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab 87: 1300-1308
77. Wierup N et al. (2002) The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept 107: 63-69
78. Reimer MK et al. (2003) Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 144: 916-921
79. Salehi A et al. (2004) Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice. Regul Pept 118: 143-150
80. Dezaki K et al. (2006) Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 55: 3486-3493
81. Dezaki K et al. (2004) Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in β-cells: implication in the glycemic control in rodents. Diabetes 53: 3142-3151
82. Dezaki K et al.: Ghrelin employs G?i2 and activates Kv channels to attenuate glucose-induced Ca2+ signaling and insulin release in islet β-cells: novel signal transduction of ghrelin. Diabetes, in press
83. Doi A et al. (2006) IA-2β, but not IA-2, is induced by ghrelin and inhibits glucose-stimulated insulin secretion. Proc Natl Acad Sci USA 103: 885-890
84. Irako T et al. (2006) Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats. Diabetologia 49: 1264-1273
85. Aimaretti G et al. (2004) GHRH and GH secretagogues: clinical perspectives and safety. Pediatr Endocrinol Rev 2 (suppl 1): 86-92
86. Tschop M et al. (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes 50: 707-709
87. Horvath TL et al. (2003) Ghrelin as a potential anti-obesity target. Curr Pharm Des 9: 1383-1395
88. Wortley KE et al. (2005) Absence of ghrelin protects against early-onset obesity. J Clin Invest 115: 3573-3578
89. Grove KL and Cowley MA (2005) Is ghrelin a signal for the development of metabolic systems? J Clin Invest 115: 3393-3397
90. Cummings DE and Schwartz MW (2003) Genetics and pathophysiology of human obesity. Annu Rev Med 54: 453-471
91. DelParigi A et al. (2002) High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome. J Clin Endocrinol Metab 87: 5461-5464
92. Isgaard J and Johansson I (2005) Ghrelin and GHS on cardiovascular applications/functions. J Endocrinol Invest 28: 838-842
93. Nagaya N et al. (2006) Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia. Intern Med 45: 127-134
94. Murray CD et al. (2005) Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 54: 1693-1698